Evidence map›Paper›PMID 40384313›Full record

ArticleSmall methods2025

Single Extracellular Vesicle Profiling to Define Brain Specific Traumatic Brain Injury Induced Neuro-Inflammation.

Zhen Zhang, Richard J Lobb, Rebecca E Lane, Xuan Vinh To, Xueming Niu, Fiach Antaw, Giovanni Pietrogrande, Craig Winter, Alain Wuethrich, Fatima Nasrallah and 1 more

Abstract read
In one paragraph

Article in Small methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zhen ZhangCentre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Saint Lucia, QLD, 4067, Australia.ORCID https://orcid.org/0000-0002-5766-3468
Richard J LobbCentre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Saint Lucia, QLD, 4067, Australia.ORCID https://orcid.org/0000-0001-9548-8843
Rebecca E LaneCentre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Saint Lucia, QLD, 4067, Australia.
Xuan Vinh ToThe Queensland Brain Institute, The University of Queensland, Saint Lucia, QLD, 4067, Australia.
Xueming NiuCentre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Saint Lucia, QLD, 4067, Australia.
Fiach AntawCentre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Saint Lucia, QLD, 4067, Australia.
Giovanni PietrograndeAustralian Institute for Bioengineering and Nanotechnology, The University of Queensland, Saint Lucia, QLD, 4067, Australia.
Craig WinterDepartment of Neurosurgery, Royal Brisbane and Women's Hospital, Herston, QLD, 4006, Australia.
Alain WuethrichCentre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Saint Lucia, QLD, 4067, Australia.
Fatima NasrallahThe Queensland Brain Institute, The University of Queensland, Saint Lucia, QLD, 4067, Australia.
Matt TrauCentre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Saint Lucia, QLD, 4067, Australia.

Funding

Australian Research Council DP220100960National Health and Medical Research Council APP2019260National Health and Medical Research Council APP2034488
6 · The paper itself

Abstract

Traumatic Brain Injury (TBI) triggers secondary molecular processes that contribute to mortality and morbidity. Neuroinflammation is a key factor affecting patient outcomes both acutely and chronically. Traditional diagnostic tools, such as computed tomography imaging and the Glasgow Coma Scale, are limited in detecting molecular changes, particularly related to neuroinflammation. Small extracellular vesicles (sEVs) are cell-specific vesicles that enable cell-to-cell communication and are involved in TBI pathology. In this study, brain-specific sEVs are isolated by targeting brain-associated markers, sodium/potassium-transporting ATPase subunit beta-2 (ATP1B2) and excitatory amino acid transporter 2 (EAAT2), and employed surface-enhanced Raman spectroscopy to profile inflammation-associated cytokine chemokine (C-C motif) ligand 2 (CCL2) bound to single sEV, allowing for blood-based monitoring of neuroinflammation. This approach enabled the direct assessment of neuroinflammation in both human TBI samples and a controlled cortical injury in a rat model. This study found elevated brain-specific sEVs with enhanced CCL2 in TBI samples compared to non-TBI cohorts. The results suggest that the TBI diagnostic platform can detect an increased level of brain-specific sEVs carrying neuroinflammatory signals in TBI clinical samples with high specificity and sensitivity, offering potential as a precise diagnostic tool for TBI diagnosis.

Indexed as

Brain Injuries, TraumaticExtracellular VesiclesNeuroinflammatory DiseasesAdultAnimalsBiomarkersBrainChemokine CCL2Disease Models, AnimalFemaleHumansMaleMiddle AgedRatsRats, Sprague-DawleyBiomarkersChemokine CCL2cytokineextracellular vesicleliquid biopsyneuroinflammationTBI

Identifiers

PMID40384313
PMCPMC12285632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.